AR117944A1 - INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSES - Google Patents

INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSES

Info

Publication number
AR117944A1
AR117944A1 ARP190100600A ARP190100600A AR117944A1 AR 117944 A1 AR117944 A1 AR 117944A1 AR P190100600 A ARP190100600 A AR P190100600A AR P190100600 A ARP190100600 A AR P190100600A AR 117944 A1 AR117944 A1 AR 117944A1
Authority
AR
Argentina
Prior art keywords
biomolecules
immune responses
intracellular delivery
modify immune
cells
Prior art date
Application number
ARP190100600A
Other languages
Spanish (es)
Original Assignee
Sqz Biotechnologies Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sqz Biotechnologies Co filed Critical Sqz Biotechnologies Co
Publication of AR117944A1 publication Critical patent/AR117944A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente solicitud proporciona células T que comprende un antígeno y un adyuvante, métodos de preparación de tales células T y métodos de uso de tales células T, como para modular una respuesta inmune en un individuo.The present application provides T cells comprising an antigen and an adjuvant, methods of preparing such T cells and methods of using such T cells, such as to modulate an immune response in an individual.

ARP190100600A 2018-03-12 2019-03-11 INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSES AR117944A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862641987P 2018-03-12 2018-03-12

Publications (1)

Publication Number Publication Date
AR117944A1 true AR117944A1 (en) 2021-09-08

Family

ID=78076061

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190100600A AR117944A1 (en) 2018-03-12 2019-03-11 INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSES

Country Status (1)

Country Link
AR (1) AR117944A1 (en)

Similar Documents

Publication Publication Date Title
CO2020012584A2 (en) Intracellular supply of biomolecules to modify immune responses
CO2021012581A2 (en) Delivery of biomolecules to pbmcs to modify an immune response
CL2019002036A1 (en) Antibody against bcma and its use.
AR118725A2 (en) VECTORS FOR EXPRESSION OF ANTIGENS ASSOCIATED WITH PROSTATE
CO2019003154A2 (en) Anti-PD-1 antibodies and their uses
CO2019007092A2 (en) Synthetic immune receptors and methods of using them
DOP2018000259A (en) BISPECIFIC UNION PROTEINS THAT JOIN AN IMMUNOMODULATORY PROTEIN AND A TUMORAL ANTIGEN
BR112018074463A2 (en) anti-tim-3 antibodies and methods of use.
CO2018012699A2 (en) Anti-CD40 antibodies and their uses
CO2019007288A2 (en) Anti-ox40 antibodies and their uses
BR112015023515A2 (en) engineered liver tissues, their matrices and methods of preparing them
CR20170419A (en) NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCER CANCER AND OTHER TYPES OF CANCER.
CR20180027A (en) NEW PEPTIDES AND NEW COMBINATIONS OF PEPTIDES FOR USE IN THE SAME THERAPY AGAINST OVARY EPITELIAL CANCER AND OTHER TYPES OF CANCER.
CR20160141A (en) ANTI-PDL1 ANTIBODY FORMULATIONS
CR20160314A (en) ANTI-CD3 ANTIBODIES AND METHODS OF USE
EP4218810A3 (en) Multivalent meditopes, meditope-binding antibodies and uses thereof
NI201600127A (en) TATk-CDKL5 FUSION PROTEINS, COMPOSITIONS, FORMULATIONS AND USE OF THEM.
CL2019000019A1 (en) Antibodies with low immunogenicity and use thereof
CU20210041A7 (en) IMMUNOGENIC PEPTIDES WITH OXIDOREDUCTASE MOTIFS
WO2016090035A3 (en) Modulators of activin and methods for modulating immune responses and t follicular helper cells
AR089995A1 (en) ROTAVIRUS SUBUNITIES VACCINES, METHODS OF PREPARATION AND USE OF THE SAME
EP4316497A3 (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
AR117944A1 (en) INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSES
CL2023001140A1 (en) Anti-pd-l1 antibody formulations
AR112602A1 (en) ANTI-TrkB ANTIBODIES